Bio-IT World October 17, 2024
Bio-IT World Staff

Illumina unveiled its MiSeq i100 Series of sequencing systems last week during an online customer event, comprising two new benchtop instruments: MiSeq i100 and MiSeq i100 Plus Systems. The MiSeq i100 will be available to ship globally in 2025.

The company says the new sequencing systems offer an affordable, comprehensive solution that is simple to understand and use, even for those with limited NGS expertise.

“Our customers told us they need a faster, smaller, and easy-to-use instrument, and that’s what we’re delivering with the MiSeq i100,” said Jacob Thaysen, PhD, CEO of Illumina, in a press release. He called the i100 series, “the plug-and-play flexibility that today’s labs are seeking.”

...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Pharma / Biotech, Precision Medicine
Advancing Cancer Care: The Role of Radiopharmaceuticals in Precision Medicine
Exploring Precision Medicine and PGx: Sara Rogers, PharmD, Previews Precision Medicine World Conference 2025
India targets to sequence 10 million genomes
23andMe considers sale as cash runs low
23andMe considers a sale as cash runs low

Share This Article